Singapore`s sovereign wealth fund Temasek Holdings has sold off 3.39 million shares in South Korean biopharma company Celltrion in a block deal worth around 865 billion won (US$764.13 million). This is the second block deal made by Temasek this year. When the first block deal took place earlier this